Our Services

Our Services
Trusted, Transparent, Tailored
Strategic Consulting
Partner with us for comprehensive strategic guidance throughout your drug development journey. We provide hands-on consulting that transforms complex challenges into clear strategies.
QD  Platform
Unlock the power of our proprietary QD [Quantify Decisions] drug development platform that revolutionizes how you build Product Development Plans and Target Product Profiles.
QD Portfolio Reports 
Get focused insights on a specific development question using our targeted QD [Quantify Decisions] portfolio reports to deliver deep analysis relevant for your decision-making.
How We Work
Seek - Select - Secure
We integrate commercial, regulatory, and clinical considerations into every decision, ensuring your drug development program is positioned for success from day one. We don't just provide advice—we quantify the impact of every strategic choice. We do this in three simple steps. 
1
Seek
We begin by understanding your strategic objectives and  drug development challenges to pinpoint the key questions and identify unique opportunities.
2
Select
We select and analyze evidence— from clinical trials data, regulatory insights to competitive intelligence — using our proprietary QD drug development platform.
3
Secure 
We transform complex data into clear, quantified recommendations that optimize plans, regulatory success, and commercial outcomes thereby securing your optimal decision-making.
Our Success Stories
Optimizing Drug Development Strategies
From LPLV to Submission
Challenge: Accelerating the complex transition from Last Patient Last Visit (LPLV) to a complete and compliant regulatory submission, while ensuring data integrity, interpretation and managing multiple stakeholders.
Outcome: Successfully streamlined process from LPLV to Submission cutting it down from 6 months to 12 days.
Regulatory Bridging 
Challenge: Navigating different regulatory requirements across key global markets to secure broadest possible label for innovative therapy without requiring redundant clinical trials.
Outcome: Multiple examples of re-using data across trials to get new dose regimens approved, avoiding new clinical trials and supporting new patient populations.
QD Report to Differentiate
Challenge: Clearly articulating the unique value proposition of a new drug in a competitive therapeutic area to patients, key opinion leaders and payers, ensuring strong market uptake.
Outcome: Quantified Decision (QD) portfolio reports utilized to highlight differentiated offering with superior efficacy and safety profiles and addressing unmet patient needs.
Pharm·ology ApS
contact@pharmology.dk
CVR: 45557898